Literature DB >> 21586687

Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers.

J C Haan1, T E Buffart, P P Eijk, M A van de Wiel, W N van Wieringen, P D Howdle, C J J Mulder, C J van de Velde, P Quirke, I D Nagtegaal, N C T van Grieken, H Grabsch, G A Meijer, B Ylstra.   

Abstract

BACKGROUND: Small bowel adenocarcinoma (SBA) is a rare cancer and consequently, the options for clinical trials are limited. As they are treated according to either a colorectal or a gastric cancer regimen and the molecular biology of a tumor is a pivotal determinant for therapy response, chromosomal copy number aberrations were compared with the colorectal and gastric adenocarcinomas.
MATERIALS AND METHODS: A total of 85 microsatellite stable (MSS) adenocarcinomas from the stomach, colorectum and small bowel were selected from existing array comparative genomic hybridization (aCGH) datasets. We compared the aCGH profiles of the three tumor sites by supervised analysis and hierarchical clustering.
RESULTS: Hierarchical clustering revealed substantial overlap of 27 SBA copy number profiles with matched colorectal adenocarcinomas but less overlap with profiles of gastric adenocarcinomas. DNA copy number aberrations located at chromosomes 1p36.3-p34.3, 4p15.3-q35.2, 9p24.3-p11.1, 13q13.2-q31.3 and 17p13.3-p13.2 were the strongest features discriminating SBAs and colorectal adenocarcinomas from gastric adenocarcinomas.
CONCLUSIONS: We show that MSS SBAs are more similar to colorectal than to gastric cancer, based on the 27 genome-wide DNA copy number profiles that are currently available. These molecular similarities provide added support for treatment of MSS small bowel cancers according to colorectal cancer regimens.

Entities:  

Mesh:

Year:  2011        PMID: 21586687     DOI: 10.1093/annonc/mdr122

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  19 in total

Review 1.  Unusual case of primary adenocarcinoma of the small bowel and lung occurring in a patient: a case report and review of literature.

Authors:  Meron Tesfay; D Ding Xianzhong; Nishant Poddar
Journal:  J Gastrointest Cancer       Date:  2015-03

2.  Establishing a standard of care for small bowel adenocarcinomas: challenges and lessons learned.

Authors:  Thorvardur R Halfdanarson; Axel Grothey
Journal:  Oncologist       Date:  2012-08-24

3.  Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy.

Authors:  Takahiro Tsushima; Masataka Taguri; Yoshitaka Honma; Hideaki Takahashi; Shinya Ueda; Tomohiro Nishina; Hiroki Kawai; Shunsuke Kato; Mitsukuni Suenaga; Fumio Tamura; Satoshi Morita; Narikazu Boku
Journal:  Oncologist       Date:  2012-05-23

4.  Clinical use of molecular targeted agents for primary small bowel adenocarcinoma: A multicenter retrospective cohort study by the Osaka Gut Forum.

Authors:  Motohiro Hirao; Masato Komori; Tsutomu Nishida; Hideki Iijima; Shinjiro Yamaguchi; Ryu Ishihara; Yuichi Yasunaga; Ichizo Kobayashi; Osamu Kishida; Masahide Oshita; Hideki Hagiwara; Toshifumi Ito; Kunio Suzuki; Yoshito Hayashi; Takahiro Inoue; Masahiko Tsujii; Harumasa Yoshihara; Tetsuo Takehara
Journal:  Oncol Lett       Date:  2017-06-01       Impact factor: 2.967

Review 5.  Small bowel adenocarcinomas--existing evidence and evolving paradigms.

Authors:  Kanwal Raghav; Michael J Overman
Journal:  Nat Rev Clin Oncol       Date:  2013-07-30       Impact factor: 66.675

6.  Genomic Profiling of Small-Bowel Adenocarcinoma.

Authors:  Alexa B Schrock; Craig E Devoe; Robert McWilliams; James Sun; Thomas Aparicio; Philip J Stephens; Jeffrey S Ross; Richard Wilson; Vincent A Miller; Siraj M Ali; Michael J Overman
Journal:  JAMA Oncol       Date:  2017-11-01       Impact factor: 31.777

Review 7.  Primary small-bowel malignancy: update in tumor biology, markers, and management strategies.

Authors:  Santosh Shenoy
Journal:  J Gastrointest Cancer       Date:  2014-12

8.  Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis.

Authors:  Laura L Meijer; Anna J Alberga; Jacob K de Bakker; Hans J van der Vliet; Tessa Y S Le Large; Nicole C T van Grieken; Ralph de Vries; Freek Daams; Barbara M Zonderhuis; Geert Kazemier
Journal:  Ann Surg Oncol       Date:  2018-06-26       Impact factor: 5.344

9.  Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.

Authors:  T Aparicio; M Svrcek; A Zaanan; E Beohou; A Laforest; P Afchain; Emmanuel Mitry; J Taieb; F Di Fiore; J-M Gornet; A Thirot-Bidault; I Sobhani; D Malka; T Lecomte; C Locher; F Bonnetain; P Laurent-Puig
Journal:  Br J Cancer       Date:  2013-11-05       Impact factor: 7.640

10.  A New Metastatic Lymph Node Classification-based Survival Predicting Model in Patients With Small Bowel Adenocarcinoma: A Derivation and Validation Study.

Authors:  Shan Wu; Jin-Nan Chen; Qing-Wei Zhang; Chao-Tao Tang; Xin-Tian Zhang; Ming-Yu Tang; Xiao-Bo Li; Zhi-Zheng Ge
Journal:  EBioMedicine       Date:  2018-06-13       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.